Krystal Biotech, Inc. (KRYS) on GreekSoup https://greeksoup.ai/stocks/us/krys/ Every dated entry in the public record on Krystal Biotech, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Krystal Biotech, Inc.: short interest 3,163,642 shares at the 15 September 2026 settlement, 13.23 days to coverhttps://greeksoup.ai/stocks/us/krys/short-interest/us:KRYS:short-interest:2026-09-15:0111d64502Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Form 144, SUMA KRISHNAN plans to sell 25,000 shares worth $9.3 million around 4 September 2026https://greeksoup.ai/stocks/us/krys/planned-sales/us:KRYS:planned-sale:2026-09-04:8daa8e0a29Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Form 144, KRISH KRISHNAN plans to sell 25,000 shares worth $9.3 million around 4 September 2026https://greeksoup.ai/stocks/us/krys/planned-sales/us:KRYS:planned-sale:2026-09-04:cbbdafb7a6Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 520 shares at $354.54 on 4 September 2026, $184,361https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:1fafaf45ceFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 2,006 shares at $355.57 on 4 September 2026, $713,277https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:6a2424e2ceFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 3,267 shares at $356.37 on 4 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:0d6f042e1fFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 3,962 shares at $357.57 on 4 September 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:43e422e274Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 3,180 shares at $358.42 on 4 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:8705ea69f9Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 3,392 shares at $359.39 on 4 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:78cd10f3e7Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 2,320 shares at $360.47 on 4 September 2026, $836,281https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:8506dfc97bFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 1,242 shares at $361.61 on 4 September 2026, $449,120https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:37dbb5325cFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 1,992 shares at $362.65 on 4 September 2026, $722,404https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:de8302420fFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 565 shares at $363.34 on 4 September 2026, $205,287https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:f36dea8575Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 1,329 shares at $364.48 on 4 September 2026, $484,390https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:e6b8909675Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 826 shares at $365.41 on 4 September 2026, $301,832https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:d1bbe3af0cFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Suma (President, R&D) sold 399 shares at $366.56 on 4 September 2026, $146,256https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:54f1459619Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 520 shares at $354.54 on 4 September 2026, $184,361https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:210ba41abcFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 2,029 shares at $355.57 on 4 September 2026, $721,455https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:497a1649f9Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 3,297 shares at $356.37 on 4 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:cbc6880200Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 3,981 shares at $357.57 on 4 September 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:716b9d1a11Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 3,143 shares at $358.42 on 4 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:9247202e40Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 3,357 shares at $359.39 on 4 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:efb118f5e0Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 2,266 shares at $360.46 on 4 September 2026, $816,809https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:8a45320ca9Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 1,214 shares at $361.61 on 4 September 2026, $438,993https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:c3eb06266dFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 2,010 shares at $362.65 on 4 September 2026, $728,927https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:f2608807ddFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 573 shares at $363.34 on 4 September 2026, $208,195https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:b0a89d2e15Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 1,358 shares at $364.48 on 4 September 2026, $494,963https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:d8bb9acf89Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 847 shares at $365.42 on 4 September 2026, $309,508https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:1c1c1d09eaFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Krishnan Krish S (President and CEO) sold 405 shares at $366.56 on 4 September 2026, $148,455https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-09-04:7f806c9944Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: short interest 3,347,813 shares at the 31 August 2026 settlement, 15.27 days to coverhttps://greeksoup.ai/stocks/us/krys/short-interest/us:KRYS:short-interest:2026-08-31:efaa22052bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Form 144, Dino A. Rossi plans to sell 25,000 shares worth $8.3 million around 14 August 2026https://greeksoup.ai/stocks/us/krys/planned-sales/us:KRYS:planned-sale:2026-08-14:bf1cff2be6Fri, 14 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 341 shares at $325.60 on 14 August 2026, $111,029https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:59c1cb627bFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 2,287 shares at $326.60 on 14 August 2026, $746,941https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:f70ef3fed3Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 5,226 shares at $327.39 on 14 August 2026, $1.7 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:05c0279dd4Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 1,687 shares at $328.52 on 14 August 2026, $554,205https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:ee51a4e461Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 7,428 shares at $329.60 on 14 August 2026, $2.4 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:ccfb11ef96Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 4,896 shares at $330.36 on 14 August 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:1991cb2066Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 3,095 shares at $331.43 on 14 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:305b60f6a7Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: Rossi Dino A (Director) sold 40 shares at $333.23 on 14 August 2026, $13,329https://greeksoup.ai/stocks/us/krys/insiders/us:KRYS:insider:2026-08-14:30b2ceb9f1Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: short interest 3,204,909 shares at the 14 August 2026 settlement, 10.32 days to coverhttps://greeksoup.ai/stocks/us/krys/short-interest/us:KRYS:short-interest:2026-08-14:fa0468dc28Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc. Q2 FY2026 results: revenue $119 million, net income $55 millionhttps://greeksoup.ai/stocks/us/krys/results/fy2026-q2/us:KRYS:result:2026-08-03:7c1100590fMon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/krys/filings/us:KRYS:filing:2026-08-03:e63de8123aMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/krys/filings/us:KRYS:filing:2026-08-03:fc596aef49Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: short interest 3,202,260 shares at the 31 July 2026 settlement, 4.15 days to coverhttps://greeksoup.ai/stocks/us/krys/short-interest/us:KRYS:short-interest:2026-07-31:ee9e619f8bFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/krys/filings/us:KRYS:filing:2026-07-21:2b875398d7Tue, 21 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Krystal Biotech, Inc.: short interest 3,496,648 shares at the 15 July 2026 settlement, 11.38 days to coverhttps://greeksoup.ai/stocks/us/krys/short-interest/us:KRYS:short-interest:2026-07-15:9d06d56872Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>